October 31th , 2017
World Immunotherapy Congress, Basel, Switzerland.
Frédéric Triebel
is speaking about TACTI-mel, two ACTive immunotherapies in melanoma: combination of an APC activator (IMP321 or LAG-3Ig) with Pembrolizumab at 5:50 PM.

November 08-12, 2017
SITC, Society for Immunotherapy of Cancer, National Harbor, MD, USA